Vaskulitis mimics

Zusammenfassung

Idiopathische Vaskulitiden sind seltene entzündliche Systemerkrankungen, die nach der Chapel-Hill Konsensus-Nomenklatur nach der Größe der prädominant betroffenen Gebiete von Blutgefäßen (große, mittelgroße, kleine Gefäße und Gefäße variabler Größe) eingeteilt werden. Vaskulitis mimics sind Syndrome, die ein ähnliches klinisches Bild hervorrufen oder leicht mit einer idiopathischen Vaskulitis verwechselt werden und teils sogar ein Krankheitsbild, das klinisch und histologisch einer Vaskulitis gleicht, auslösen können. Die Zahl der Vaskulitis mimics ist groß, je nach betroffenem Gefäßgebiet kommen hereditäre Erkrankungen des Bindegewebes, genetisch bedingte Immundefekt- und Autoinflammationssyndrome, infektiöse Erkrankungen, seltene entzündliche Systemerkrankungen, Tumorerkrankungen, medikamenteninduzierte Syndrome und zahlreiche weitere infrage. In diesem Review wird eine Auswahl klassischer Imitatoren von Vaskulitiden, orientiert an der Größe der betroffenen Blutgefäße präsentiert und Konstellationen, die typische „Fallstricke“ in der klinischen Abklärung darstellen können, diskutiert.

Abstract

Idiopathic vasculitides are rare inflammatory systemic diseases grouped in the Chapel-Hill concensus nomenclature by the size of the predominantly affected vessels (large, medium, small and variable vessel vasculitis). Vasculitis mimics are syndromes that cause a clinical image similar to idiopathic vasculitides or can easily be confused with them. Sometimes they even cause the full-blown clinical and histological pattern of a vasculitis disease. There are numerous vasculitis mimics: depending on the affected vessel size, hereditary connective tissue diseases, genetic immunodeficiency and autoinflammatory syndromes, infectious diseases, rare inflammatory systemic diseases, malignancies, drug-induced syndromes and several others should be considered. This review presents a selection of classical mimickers of vasculitides grouped by vessel size and discusses constellations that can be typical “pitfalls” in the clinical workup.

Schlüsselwörter

Riesenzellarteriitis - medikamenteninduziert - infektiöse Aortitis - Endokarditis - ANCA

Key words

drug-induced - infectious aortitis - endocarditis - ANCA - giant-cell arteritis

Publication History

Article published online:
20 February 2023

• Literatur

• 1 Jennette JC, Falk RJ, Bacon PA. et al. 2012 revised International Chapel Hill Consensus Conference Nomenclature of Vasculitides. Arthritis Rheum 2013; 65: 1-11 DOI: 10.1002/art.37715.
• 2 Dammacco F, Lauletta G, Russi S. et al. Clinical practice: hepatitis C virus infection, cryoglobulinemia and cryoglobulinemic vasculitis. Clin Exp Med 2019; 19: 1-21 DOI: 10.1007/s10238-018-0536-z.
• 3 Schirmer JH, Moosig F. [Update: polyarteritis nodosa]. Z Rheumatol 2018; 77: 397-408 DOI: 10.1007/s00393-018-0469-7.
• 4 Schirmer JH, Aries PM, Balzer K. et al. [S2k guidelines: management of large-vessel vasculitis]. Z Rheumatol 2020; 79: 67-95 DOI: 10.1007/s00393-020-00893-1.
• 5 Dejaco C, Ramiro S, Duftner C. et al. EULAR recommendations for the use of imaging in large vessel vasculitis in clinical practice. Ann Rheum Dis 2018; 77: 636-643 DOI: 10.1136/annrheumdis-2017-212649.
• 6 Milewicz DM, Braverman AC, De Backer J. et al. Marfan syndrome. Nat Rev Dis Primers 2021; 7: 64 DOI: 10.1038/s41572-021-00298-7.
• 7 Requejo-Garcia L, Martinez-Lopez R, Plana-Andani E. et al. Extra-Thoracic Aneurysms in Marfan Syndrome: A Systematic Review of the Literature. Ann Vasc Surg 2022; S0890-5096: 00505-2 DOI: 10.1016/j.avsg.2022.08.005.
• 8 Malfait F, Francomano C, Byers P. et al. The 2017 international classification of the Ehlers-Danlos syndromes. Am J Med Genet C Semin Med Genet 2017; 175: 8-26 DOI: 10.1002/ajmg.c.31552.
• 9 Benrashid E, Ohman JW. Current management of the vascular subtype of Ehlers-Danlos syndrome. Curr Opin Cardiol 2020; 35: 603-609 DOI: 10.1097/HCO.0000000000000797.
• 10 Rashed ER, Ruiz Maya T, Black J. et al. Cardiovascular manifestations of hypermobile Ehlers-Danlos syndrome and hypermobility spectrum disorders. Vasc Med 2022; 27: 283-289 DOI: 10.1177/1358863X211067566.
• 11 Loeys BL, Chen J, Neptune ER. et al. A syndrome of altered cardiovascular, craniofacial, neurocognitive and skeletal development caused by mutations in TGFBR1 or TGFBR2. Nat Genet 2005; 37: 275-281 DOI: 10.1038/ng1511.
• 12 Loeys BL, Schwarze U, Holm T. et al. Aneurysm syndromes caused by mutations in the TGF-beta receptor. N Engl J Med 2006; 355: 788-798 DOI: 10.1056/NEJMoa055695.
• 13 Gouda P, Kay R, Habib M. et al. Clinical features and complications of Loeys-Dietz syndrome: A systematic review. Int J Cardiol 2022; 362: 158-167 DOI: 10.1016/j.ijcard.2022.05.065.
• 14 Oderich GS, Sullivan TM, Bower TC. et al. Vascular abnormalities in patients with neurofibromatosis syndrome type I: clinical spectrum, management, and results. J Vasc Surg 2007; 46: 475-484 DOI: 10.1016/j.jvs.2007.03.055.
• 15 Iwanaga A, Utani A, Koike Y. et al. Clinical practice guidelines for pseudoxanthoma elasticum (2017): Clinical Practice Guidelines for Pseudoxanthoma Elasticum Drafting Committee. J Dermatol 2022; 49: e91-e98 DOI: 10.1111/1346-8138.16301.
• 16 Hiratzka LF, Bakris GL, Beckman JA. et al. 2010 ACCF/AHA/AATS/ACR/ASA/SCA/SCAI/SIR/STS/SVM guidelines for the diagnosis and management of patients with Thoracic Aortic Disease: a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, American Association for Thoracic Surgery, American College of Radiology, American Stroke Association, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society of Thoracic Surgeons, and Society for Vascular Medicine. Circulation 2010; 121: e266-e369 DOI: 10.1161/CIR.0b013e3181d4739e.
• 17 Cox K, Sundaram RD, Popescu M. et al. A review on the deeper understanding of inflammation and infection of the thoracic aorta. Vascular 2022; 17085381211060928 DOI: 10.1177/17085381211060928.
• 18 Fernández-Fernández E, Monjo-Henry I, Bonilla G. et al. False positives in the ultrasound diagnosis of giant cell arteritis: Some diseases can also show the halo sign. Rheumatology 2020; 59: 2443-2447 DOI: 10.1093/rheumatology/kez641.
• 19 Czihal M, Köhler A, Prearo I. et al. Hyperechogenic intimal lesions and wall thickness of the temporal and facial arteries in elderly patients with arterial occlusions of the eye. RMD Open 2021; 7: e001688 DOI: 10.1136/rmdopen-2021-001688.
• 20 Nienhuis PH, van Praagh GD, Glaudemans AWJM. et al. A Review on the Value of Imaging in Differentiating between Large Vessel Vasculitis and Atherosclerosis. J Pers Med 2021; 11: 236 DOI: 10.3390/jpm11030236.
• 21 Hayreh SS. Management of ischemic optic neuropathies. Indian J Ophthalmol 2011; 59: 123-136 DOI: 10.4103/0301-4738.77024.
• 22 Kermani TA, Schmidt J, Crowson CS. et al. Utility of erythrocyte sedimentation rate and C-reactive protein for the diagnosis of giant cell arteritis. Semin Arthritis Rheum 2012; 41: 866-871 DOI: 10.1016/j.semarthrit.2011.10.005.
• 23 Lecler A, Obadia M, Savatovsky J. et al. TIPIC Syndrome: Beyond the Myth of Carotidynia, a New Distinct Unclassified Entity. AJNR Am J Neuroradiol 2017; 38: 1391-1398 DOI: 10.3174/ajnr.A5214.
• 24 Micieli E, Voci D, Mumoli N. et al. Transient perivascular inflammation of the carotid artery (TIPIC) syndrome. Vasa 2022; 51: 71-77 DOI: 10.1024/0301-1526/a000989.
• 25 Czihal M, Löw A, Lottspeich C. et al. TIPIC syndrome associated to arteriosclerosis of the carotid bifurcation. Vasa 2022; 51: 323-325 DOI: 10.1024/0301-1526/a001021.
• 26 James KE, Kalot MA, Husainat NM. et al. Kawasaki Disease: A Systematic Review and Meta-Analysis of Benefits and Harms of Common Treatments. ACR Open Rheumatol 2021; 3: 671-683 DOI: 10.1002/acr2.11308.
• 27 Brinza EK, Gornik HL. Fibromuscular dysplasia: Advances in understanding and management. Cleve Clin J Med 2016; 83: S45-S51 DOI: 10.3949/ccjm.83.s2.06.
• 28 Kalva SP, Somarouthu B, Jaff MR. et al. Segmental arterial mediolysis: Clinical and imaging features at presentation and during follow-up. J Vasc Intervent Radiol 2011; 22: 1380-1387 DOI: 10.1016/j.jvir.2011.07.001.
• 29 Skeik N, Olson SL, Hari G. et al. Segmental arterial mediolysis (SAM): Systematic review and analysis of 143 cases. Vasc Med 2019; 24: 549-563 DOI: 10.1177/1358863X19873410.
• 30 Abu Sneineh M, Farkas A, Natsheh A. et al. Segmental arterial mediolysis: a vasculitis mimicker. A single centre experience. Clin Exp Rheumatol 2020; 38: 148-154
• 31 Slavin RE, Saeki K, Bhagavan B. et al. Segmental arterial mediolysis: a precursor to fibromuscular dysplasia?. Mod Pathol 1995; 8: 287-294
• 32 Saric M, Kronzon I. Cholesterol embolization syndrome. Curr Opin Cardiol 2011; 26: 472-479 DOI: 10.1097/HCO.0b013e32834b7fdd.
• 33 Gallo Marin B, Aghagoli G, Hu SL. et al. Calciphylaxis and Kidney Disease: A Review. American Journal of Kidney Diseases 2022; S0272638622008496 DOI: 10.1053/j.ajkd.2022.06.011.
• 34 Almaani S, Fussner LA, Brodsky S. et al. Anca-associated vasculitis: An update. Journal of Clinical Medicine 2021; 10 DOI: 10.3390/jcm10071446.
• 35 Pendergraft WF, Niles JL. Trojan horses: drug culprits associated with antineutrophil cytoplasmic autoantibody (ANCA) vasculitis. Curr Opin Rheumatol 2014; 26: 42-49 DOI: 10.1097/BOR.0000000000000014.
• 36 European Monitoring Centre for Drugs and Drug Addiction. Europäischer Drogenbericht 2021: Trends und Entwicklungen. LU: Publications Office; 2021
• 37 Dartevel A, Chaigne B, Moachon L. et al. Levamisole-induced vasculopathy: A systematic review. Semin Arthritis Rheum 2019; 48: 921-926 DOI: 10.1016/j.semarthrit.2018.07.010.
• 38 Chang A, Osterloh J, Thomas J. Levamisole: A Dangerous New Cocaine Adulterant. Clin Pharmacol Ther 2010; 88: 408-411 DOI: 10.1038/clpt.2010.156.
• 39 Wolford A, McDonald TS, Eng H. et al. Immune-mediated agranulocytosis caused by the cocaine adulterant levamisole: a case for reactive metabolite(s) involvement. Drug Metab Dispos 2012; 40: 1067-1075 DOI: 10.1124/dmd.112.045021.
• 40 Martins AM, Marto JM, Johnson JL. et al. A Review of Systemic Minocycline Side Effects and Topical Minocycline as a Safer Alternative for Treating Acne and Rosacea. Antibiotics (Basel) 2021; 10: 757 DOI: 10.3390/antibiotics10070757.
• 41 Kermani TA, Ham EK, Camilleri MJ. et al. Polyarteritis Nodosa-like Vasculitis in Association with Minocycline Use: A Single-Center Case Series. Semin Arthritis Rheum 2012; 42: 213-221 DOI: 10.1016/j.semarthrit.2012.03.006.
• 42 Arai N, Nemoto K, Oh-Ishi S. et al. Methimazole-induced ANCA-associated vasculitis with diffuse alveolar haemorrhage. Respirol Case Rep 2018; 6: e00315 DOI: 10.1002/rcr2.315.
• 43 Mavrakanas TA, Bouatou Y, Samer C. et al. Carbimazole-induced, ANCA-associated, crescentic glomerulonephritis: case report and literature review. Ren Fail 2013; 35: 414-417 DOI: 10.3109/0886022X.2012.760356.
• 44 Yaseen K, Nevares A, Tamaki H. A Spotlight on Drug-Induced Vasculitis. Curr Rheumatol Rep 2022; 24: 323-336 DOI: 10.1007/s11926-022-01088-0.
• 45 Bertlich M, Ihler F, Bertlich I. et al. Management of chronic rhinosinusitis with nasal polyps in Samter triad by low-dose ASA desensitization or dupilumab. Medicine (Baltimore) 2021; 100: e27471 DOI: 10.1097/MD.0000000000027471.
• 46 Schunkert EM, Divito SJ. Updates and Insights in the Diagnosis and Management of DRESS Syndrome. Curr Dermatol Rep 2021; 10: 192-204 DOI: 10.1007/s13671-021-00348-z.
• 47 Schirmer JH, Hoyer BF. Hypereosinophilic syndrome and other rheumatic diseases with hypereosinophilia. Z Rheumatol 2019; 78: 322-332 DOI: 10.1007/s00393-019-0623-x.
• 48 Klion A. Hypereosinophilic syndrome: approach to treatment in the era of precision medicine. Hematology Am Soc Hematol Educ Program 2018; 2018: 326-331 DOI: 10.1182/asheducation-2018.1.326.
• 49 Holle JU, Gross WL, Holl-Ulrich K. et al. Prospective long-term follow-up of patients with localised Wegener’s granulomatosis: Does it occur as persistent disease stage?. Ann Rheum Dis 2010; 69: 1934-1939 DOI: 10.1136/ard.2010.130203.
• 50 Hellmich B, Flossmann O, Gross WL. et al. EULAR recommendations for conducting clinical studies and/or clinical trials in systemic vasculitis: focus on anti-neutrophil cytoplasm antibody-associated vasculitis. Ann Rheum Dis 2007; 66: 605-617 DOI: 10.1136/ard.2006.062711.
• 51 Pendolino AL, Unadkat S, Zhang H. et al. The role of surgery in antineutrophil cytoplasmic antibody-associated vasculitides affecting the nose and sinuses: A systematic review. SAGE Open Med 2020; 8 DOI: 10.1177/2050312120936731.
• 52 Nitro L, Pipolo C, Fadda GL. et al. Distribution of cocaine-induced midline destructive lesions: systematic review and classification. Eur Arch Otorhinolaryngol 2022; 279: 3257-3267 DOI: 10.1007/s00405-022-07290-1.
• 53 Gadola SD, Moins-Teisserenc HT, Trowsdale J. et al. TAP deficiency syndrome. Clin Exp Immunol 2000; 121: 173-178 DOI: 10.1046/j.1365-2249.2000.01264.x.
• 54 Schultz H, Schinke S, Weiss J. et al. BPI-ANCA in transporter associated with antigen presentation (TAP) deficiency: possible role in susceptibility to Gram-negative bacterial infections. Clin Exp Immunol 2003; 133: 252-259 DOI: 10.1046/j.1365-2249.2003.02197.x.
• 55 Ardeniz O, Cunningham-Rundles C. Granulomatous disease in common variable immunodeficiency. Clin Immunol 2009; 133: 198-207 DOI: 10.1016/j.clim.2009.05.001.
• 56 Gutierrez MJ, Sullivan KE, Fuleihan R. et al. Phenotypic characterization of patients with rheumatologic manifestations of common variable immunodeficiency. Semin Arthritis Rheum 2018; 48: 318-326 DOI: 10.1016/j.semarthrit.2018.02.013.
• 57 Tse E, Kwong Y-L. The diagnosis and management of NK/T-cell lymphomas. J Hematol Oncol 2017; 10: 85 DOI: 10.1186/s13045-017-0452-9.
• 58 Pedro B, Meleiro M, Marinho A. Not All ENT Granulomas Are Wegener’s - Keep Tuberculosis in Mind. European journal of case reports in internal medicine 2020; 7: 001469 DOI: 10.12890/2020_001469.
• 59 Sardana K, Goel K. Nasal septal ulceration. Clin Dermatol 2014; 32: 817-826 DOI: 10.1016/j.clindermatol.2014.02.022.
• 60 Habib G, Lancellotti P, Antunes MJ. et al. 2015 ESC Guidelines for the management of infective endocarditis: The Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC)Endorsed by: European Association for Cardio-Thoracic Surgery (EACTS), the European Association of Nuclear Medicine (EANM). Eur Heart J 2015; 36: 3075-3128 DOI: 10.1093/eurheartj/ehv319.
• 61 Ai S, Liu J, Ma G. et al. Endocarditis-associated rapidly progressive glomerulonephritis mimicking vasculitis: a diagnostic and treatment challenge. Ann Med 2022; 54: 754-763 DOI: 10.1080/07853890.2022.2046288.
• 62 Wang F, Zhou Z, Teng J. et al. The clinical pattern differentiates ANCA-positive infective endocarditis patients from ANCA-associated vasculitis patients: a 23 years’ retrospective cohort study in China and follow-ups. Clin Rheumatol 2022; DOI: 10.1007/s10067-022-06313-w.
• 63 Mahr A, Batteux F, Tubiana S. et al. Brief report: Prevalence of antineutrophil cytoplasmic antibodies in infective endocarditis. Arthritis Rheum 2014; 66: 1672-1677 DOI: 10.1002/art.38389.
• 64 Deshpande V, Zen Y, Chan JK. et al. Consensus statement on the pathology of IgG4-related disease. Mod Pathol 2012; 25: 1181-1192 DOI: 10.1038/modpathol.2012.72.
• 65 Wallace ZS, Naden RP, Chari S. et al. The 2019 American College of Rheumatology/European League Against Rheumatism classification criteria for IgG4-related disease. Ann Rheum Dis 2020; 79: 77-87 DOI: 10.1136/annrheumdis-2019-216561.
• 66 Stone JH, Brito-Zerón P, Bosch X. et al. Diagnostic Approach to the Complexity of IgG4-Related Disease. Mayo Clin Proc 2015; 90: 927-939 DOI: 10.1016/j.mayocp.2015.03.020.
• 67 Lanzillotta M, Campochiaro C, Trimarchi M. et al. Deconstructing IgG4-related disease involvement of midline structures: Comparison to common mimickers. Modern Rheumatology 2017; 27: 638-645 DOI: 10.1080/14397595.2016.1227026.
• 68 Stone JR. Aortitis, periaortitis, and retroperitoneal fibrosis, as manifestations of IgG4-related systemic disease. Curr Opin Rheumatol 2011; 23: 88-94 DOI: 10.1097/BOR.0b013e3283412f7c.
• 69 Goyal G, Heaney ML, Collin M. et al. Erdheim-Chester disease: consensus recommendations for evaluation, diagnosis, and treatment in the molecular era. Blood 2020; 135: 1929-1945 DOI: 10.1182/blood.2019003507.
• 70 Zhou Q, Yang D, Ombrello AK. et al. Early-onset stroke and vasculopathy associated with mutations in ADA2. N Engl J Med 2014; 370: 911-920 DOI: 10.1056/NEJMoa1307361.
• 71 Navon Elkan P, Pierce SB, Segel R. et al. Mutant adenosine deaminase 2 in a polyarteritis nodosa vasculopathy. N Engl J Med 2014; 370: 921-931 DOI: 10.1056/NEJMoa1307362.
• 72 Schnappauf O, Sampaio Moura N, Aksentijevich I. et al. Sequence-Based Screening of Patients With Idiopathic Polyarteritis Nodosa, Granulomatosis With Polyangiitis, and Microscopic Polyangiitis for Deleterious Genetic Variants in ADA2. Arthritis Rheum 2021; 73: 512-519 DOI: 10.1002/art.41549.
• 73 Demir S, Sag E, Dedeoglu F. et al. Vasculitis in Systemic Autoinflammatory Diseases. Front Pediatr 2018; 6: 377 DOI: 10.3389/fped.2018.00377.
• 74 Beck DB, Ferrada MA, Sikora KA. et al. Somatic Mutations in UBA1 and Severe Adult-Onset Autoinflammatory Disease. N Engl J Med 2020; 383: 2628-2638 DOI: 10.1056/NEJMoa2026834.
• 75 Watanabe R, Kiji M, Hashimoto M. Vasculitis associated with VEXAS syndrome: A literature review. Front Med (Lausanne) 2022; 9: 983939 DOI: 10.3389/fmed.2022.983939.
• 76 Ferrada MA, Sikora KA, Luo Y. et al. Somatic Mutations in UBA1 Define a Distinct Subset of Relapsing Polychondritis Patients With VEXAS. Arthritis Rheumatol 2021; 73: 1886-1895 DOI: 10.1002/art.41743.
• 77 Daxini A, Cronin K, Sreih AG. Vasculitis associated with immune checkpoint inhibitors-a systematic review. Clin Rheumatol 2018; 37: 2579-2584 DOI: 10.1007/s10067-018-4177-0.
• 78 Cho J, Quach S, Reed J. et al. Case report: left atrial Myxoma causing elevated C-reactive protein, fatigue and fever, with literature review. BMC Cardiovasc Disord 2020; 20: 119 DOI: 10.1186/s12872-020-01397-1.
• 79 Aguilar C, Carbajal T, Beltran BE. et al. Cerebral embolization associated with parenchymal seeding of the left atrial myxoma: Potential role of interleukin-6 and matrix metalloproteinases. Neuropathology 2021; 41: 49-57 DOI: 10.1111/neup.12697.
• 80 Corin J, Carlsson A, Peters B. Right atrial myxoma as the first manifestation of granulomatosis with polyangiitis, and a possible association with vascular endothelial growth factor (VEGF) and interleukin 6 (IL-6): a case report and review of the literature. Eur J Med Res 2022; 27: 4 DOI: 10.1186/s40001-022-00632-z.
• 81 Calabrese LH, Dodick DW, Schwedt TJ. et al. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 2007; 146: 34-44 DOI: 10.7326/0003-4819-146-1-200701020-00007.
• 82 Song T-J, Lee KH, Li H. et al. Reversible cerebral vasoconstriction syndrome: a comprehensive systematic review. Eur Rev Med Pharmacol Sci 2021; 25: 3519-3529 DOI: 10.26355/eurrev_202105_25834.
• 83 Pacheco K, Ortiz JF, Parwani J. et al. Reversible Cerebral Vasoconstriction Syndrome in the Postpartum Period: A Systematic Review and Meta-Analysis. Neurol Int 2022; 14: 488-496 DOI: 10.3390/neurolint14020040.
• 84 David C, Sacré K, Henri-Feugeas M-C. et al. Susac syndrome: A scoping review. Autoimmun Rev 2022; 21: 103097 DOI: 10.1016/j.autrev.2022.103097.
• 85 Paraskevas GP, Stefanou MI, Constantinides VC. et al. CADASIL in Greece: Mutational spectrum and clinical characteristics based on a systematic review and pooled analysis of published cases. Eur J Neurol 2022; 29: 810-819 DOI: 10.1111/ene.15180.
• 86 Ihara M, Yamamoto Y, Hattori Y. et al. Moyamoya disease: diagnosis and interventions. Lancet Neurol 2022; 21: 747-758 DOI: 10.1016/S1474-4422(22)00165-X.
• 87 Malhotra K, Theodorou A, Katsanos AH. et al. Prevalence of Clinical and Neuroimaging Markers in Cerebral Amyloid Angiopathy: A Systematic Review and Meta-Analysis. Stroke 2022; 53: 1944-1953 DOI: 10.1161/STROKEAHA.121.035836.
• 88 Francescone MA, Levitt J. Scurvy masquerading as leukocytoclastic vasculitis: a case report and review of the literature. Cutis 2005; 76: 261-266
• 89 Sanyal S, Tsang Y, Miller J. et al. Golfer’s purpura – an under recognised form of exercise-induced capillaritis. J Eur Acad Dermatol Venereol 2016; 30: 1403-1404 DOI: 10.1111/jdv.13247.
• 90 Saha BK, Datar P, Aiman A. et al. Comparative Analysis of Adult Patients With Idiopathic Pulmonary Hemosiderosis and Lane-Hamilton Syndrome: A Systematic Review of the Literature in the Period 1971-2022. Cureus 2022; 14: e23482 DOI: 10.7759/cureus.23482.